Assessing global transitions in human development and colorectal cancer incidence

被引:43
作者
Fidler, Miranda M. [1 ]
Bray, Freddie [1 ]
Vaccarella, Salvatore [2 ]
Soerjomataram, Isabelle [1 ]
机构
[1] Int Agcy Res Canc, Sect Canc Surveillance, 150 Cours Albert Thomas, F-69372 Lyon 08, France
[2] Int Agcy Res Canc, Sect Infect, F-69372 Lyon 08, France
关键词
cancer; incidence; human development; socioeconomic; international; colorectum; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RISK; METAANALYSIS; ASPIRIN; MORTALITY; COHORT; TRENDS;
D O I
10.1002/ijc.30686
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colorectal cancer incidence has paralleled increases in human development across most countries. Yet, marked decreases in incidence are now observed in countries that have attained very high human development. Thus, in this study, we explored the relationship between human development and colorectal cancer incidence, and in particular assessed whether national transitions to very high human development are linked to temporal patterns in colorectal cancer incidence. For these analyses, we utilized the Human Development Index (HDI) and annual incidence data from regional and national cancer registries. Truncated (30-74 years) age-standardized incidence rates were calculated. Yearly incidence rate ratios and HDI ratios, before and after transitioning to very high human development, were also estimated. Among the 29 countries investigated, colorectal cancer incidence was observed to decrease after reaching the very high human development threshold for 12 countries; decreases were also observed in a further five countries, but the age-standardized incidence rates remained higher than that observed at the threshold. Such declines or stabilizations are likely due to colorectal cancer screening in some populations, as well as varying levels of exposure to protective factors. In summary, it appears that there is a threshold at which human development predicts a stabilization or decline in colorectal cancer incidence, though this pattern was not observed for all countries assessed. Future cancer planning must consider the increasing colorectal cancer burden expected in countries transitioning towards higher levels of human development, as well as possible declines in incidence among countries reaching the highest development level. What's new? Lifestyles associated with westernization are increasingly predominant in countries where social mobility and economic growth are on the rise. The incidence of colorectal cancer (CRC) has likewise risen in those countries, though some areas with very high human development are now experiencing alternate trends. Here, CRC incidence was found to have decreased for 12 out of 29 countries that have attained very high levels of human development. Though not evident for all countries analyzed, the data suggest the existence of a threshold at which CRC incidence stabilizes or declines according to the Human Development Index.
引用
收藏
页码:2709 / 2715
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 2013, Stata Statistical Software: Release, P13
[2]  
[Anonymous], 2013, SEER STAT SOFTW VERS
[3]   Global patterns and trends in colorectal cancer incidence and mortality [J].
Arnold, Melina ;
Sierra, Monica S. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
GUT, 2017, 66 (04) :683-691
[4]   DIVERGING TRENDS IN COLORECTAL-CANCER MORBIDITY AND MORTALITY - EARLIER DIAGNOSIS COMES AT A PRICE [J].
BONNEUX, L ;
BARENDREGT, JJ ;
LOOMAN, CWN ;
van der Maas, PJ .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (10) :1665-1671
[5]   Diagnostic Performance of Guaiac-Based Fecal Occult Blood Test in Routine Screening: State-Wide Analysis from Bavaria, Germany [J].
Brenner, Hermann ;
Hoffmeister, Michael ;
Birkner, Berndt ;
Stock, Christian .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (03) :427-435
[6]   Dairy foods, calcium, and colorectal cancer: A pooled analysis of 10 cohort studies [J].
Cho, E ;
Smith-Warner, SA ;
Spiegelman, D ;
Beeson, WL ;
van den Brandt, PA ;
Colditz, GA ;
Folsom, AR ;
Fraser, GE ;
Freudenheim, JL ;
Giovannucci, E ;
Goldbohm, RA ;
Graham, S ;
Miller, AB ;
Pietinen, P ;
Potter, JD ;
Rohan, TE ;
Terry, P ;
Toniolo, P ;
Virtanen, MJ ;
Willett, WC ;
Wolk, A ;
Wu, K ;
Yaun, SS ;
Zeleniuch-Jacquotte, A ;
Hunter, DJ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (13) :1015-1022
[7]   Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence [J].
Citarda, F ;
Tomaselli, G ;
Capocaccia, R ;
Barcherini, S ;
Crespi, M .
GUT, 2001, 48 (06) :812-815
[8]   Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement [J].
Cuzick, Jack ;
Otto, Florian ;
Baron, John A. ;
Brown, Powel H. ;
Burn, John ;
Greenwald, Peter ;
Jankowski, Janusz ;
La Vecchia, Carlo ;
Meyskens, Frank ;
Senn, Hans Joerg ;
Thun, Michael .
LANCET ONCOLOGY, 2009, 10 (05) :501-507
[9]   The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors [J].
Danaei, Goodarz ;
Ding, Eric L. ;
Mozaffarian, Dariush ;
Taylor, Ben ;
Rehm, Juergen ;
Murray, Christopher J. L. ;
Ezzati, Majid .
PLOS MEDICINE, 2009, 6 (04)
[10]  
Doll R, 1966, CANC INCIDENCE 5 CON